HeartBeam Balance Sheet Health
Financial Health criteria checks 6/6
HeartBeam has a total shareholder equity of $12.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $13.6M and $1.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$12.64m |
Equity | US$12.54m |
Total liabilities | US$1.10m |
Total assets | US$13.64m |
Recent financial health updates
Recent updates
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14Financial Position Analysis
Short Term Liabilities: BEAT's short term assets ($13.2M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: BEAT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BEAT is debt free.
Reducing Debt: BEAT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BEAT has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BEAT is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.